Crossmark

Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ8-tetrahydrocannabinol: case studies

Published Online: 2022-07-07

Published Print: 2022-12

Authors

Wurz, Gregory T.

Montoya, Edward

DeGregorio, Michael W. http://orcid.org/0000-0003-4349-9158
Funding

Funding for this research was provided by:

cancer immunotherapy research institute (Not applicable)

rcu labs, inc. (Not applicable)
License Information

Text and Data Mining valid from 2022-07-07

Version of Record valid from 2022-07-07
More Information

Article History

Received: 28 June 2021

Accepted: 24 June 2022

First Online: 7 July 2022

Declarations

:

: This study was approved by the Cancer Immunotherapy Research Institute IRB, Federal Wide Assurance number FWA00029851. Written informed consent was obtained from all subjects prior to their participation, and a copy of the signed informed consent form was provided to each subject.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current